Advertisement

Topics

Dr. Reddy’s Laboratories Announces Acquisition of ANDA Portfolio

13:04 EDT 13 Apr 2019 | Biotech 365

HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) announced today that it has entered into a definitive agreement to acquire a portfolio of … Continue reading

Original Article: Dr. Reddy’s Laboratories Announces Acquisition of ANDA Portfolio

NEXT ARTICLE

More From BioPortfolio on "Dr. Reddy’s Laboratories Announces Acquisition of ANDA Portfolio"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...